Delivery Order SPE2DB22D2206-SPE2DB26FDS85
Award Date 10/22/25
Potential Completion Date 11/13/25
Potential Value $7.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,436.04 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 IU/11.7 mL on September 23, 2025, with completion targeted for October 15, 2025. This non-competitive delivery order utilizes firm fixed-price terms and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader pharmaceutical supply relationship...
- The Defense Logistics Agency awarded a delivery order valued at $4,327.94 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela (1,600 mg-26,800 13.4ml) on September 10, 2025, with completion expected by October 1, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $37,180.20 to AmerisourceBergen Drug Corp for the supply of Rituxan Hycela 1,400 mg-23,400 11.7 mL on July 25, 2025, with an ultimate completion date of August 15, 2025. This firm fixed price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive award under a larger vehicle, reflecting AmerisourceBergen's established...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 17, 2025, for the supply of Rituxan Hycela (rituximab and hyaluronidase), a specialty pharmaceutical product used in oncology and immunology treatment regimens. The contract is valued at $3,718.02 with a firm fixed price structure and an ultimate completion date of October 8, 2025. This delivery order is non-set-aside and was competitively awarded,...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,741,919 units of the pharmaceutical product Rituxan Hycela 1,600 mg-26,800 13.4 mL. The award has a potential value of $4,167.13 and a completion date of March 14, 2024. No set-aside designation was used for this contract. AmerisourceBergen Drug Corp serves as the prime contractor,...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $29,254.08 firm fixed price contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug RITUXAN HYCELA. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 through...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,400 mg-23,400 11.7 ml vials of the drug Rituxan Hycela, with a ceiling value of $74,092.00 and a completion date of June 7, 2023. The contract was awarded on May 16, 2023 and is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition....
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $22,308.12, is for the delivery of RITUXAN HYCELA 1,400 MG-23,400 11.7ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a period of performance through February 4, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite...
- The Defense Logistics Agency awarded a $14,818 delivery order to Amerisourcebergen Drug Corporation for RITUXAN HYCELA, a monoclonal antibody used to treat certain types of cancer and autoimmune disorders. The firm fixed price order is for delivery of 1,400 mg doses to a facility in Conshohocken, Pennsylvania between June and July 2023. Amerisourcebergen will fulfill the order as the prime contractor from its Corporate Office Division. No additional details were provided regarding subcontractors...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,664.56, is for the delivery of Rituxan Hycela, a specialty medication, and does not have a set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2025....